Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Other Non-Current Liabilities: 2010-2021

Historic Other Non-Current Liabilities for Neurocrine Biosciences (NBIX) over the last 10 years, with Sep 2021 value amounting to $8.3 million.

  • Neurocrine Biosciences' Other Non-Current Liabilities rose 93.02% to $8.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $8.3 million, marking a year-over-year increase of 93.02%. This contributed to the annual value of $9.7 million for FY2020, which is 43.27% down from last year.
  • Neurocrine Biosciences' Other Non-Current Liabilities amounted to $8.3 million in Q3 2021, which was down 71.38% from $29.0 million recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Other Non-Current Liabilities high stood at $35.7 million for Q4 2018, and its period low was $113,000 during Q1 2017.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $17.1 million (2019), whereas its average is $16.7 million.
  • As far as peak fluctuations go, Neurocrine Biosciences' Other Non-Current Liabilities plummeted by 63.24% in 2020, and later soared by 93.02% in 2021.
  • Neurocrine Biosciences' Other Non-Current Liabilities (Quarterly) stood at $113,000 in 2017, then reached $35.7 million in 2018, then plummeted by 52.04% to $17.1 million in 2019, then plummeted by 43.27% to $9.7 million in 2020, then spiked by 93.02% to $8.3 million in 2021.
  • Its last three reported values are $8.3 million in Q3 2021, $29.0 million for Q2 2021, and $21.3 million during Q1 2021.